Clinical Trials
2 trialsNCT02297529 2019-10-31
Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma
Amgen
No longer available
NCT02147951 2016-03-01
Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Amgen
No longer available